← brief for 2026-08-16 · Slowing decline
Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol.
Key takeaways
This phase 2a trial protocol uses NMN to treat diabetic kidney disease. It will enroll 50 patients for 6 months.
Who did this work
Chandra MS · Gagliano-Jucá T · Shekhar S · Pencina KM · Travison TG · Garg R · McDonnell ME · Reid KF · Latham NK · Lam H · Meritus D · Yan Y
Source
Article · PubMed, Lifestyle and CKD · 2026 Jul 16
https://pubmed.ncbi.nlm.nih.gov/42603990/